- Facilitator Fund award to PSU startup company DesignMedix, Inc. DesigMedic, Inc. develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. Focus is on globally-important infectious diseases such as malaria where additional drugs are urgently needed.
- Facilitator Fund award to PSU startup company Elex Biotech, Inc. Elex Biotech develops new drugs targeting the Ca2+ leak associated with ventricular arrhythmias, the leading cause of heart disease.
- Development Fund award to promote the development of the "Total Employer Cost of Compensation Tool." This tool, developed in the Center for Public Service at Portland State University, is used by municipalities in Oregon to calculate the total cost to an employer of hiring an employee.
- Facilitator Fund award to PSU startup company SweetSense, Inc. SweetSense, Inc., is developing low-power, remotely programmable sensors. Their initial focus is on the monitoring of technologies deployed in the developing world. The funds will be used to ramp up business development efforts to secure and expand customers and partnerships.
- Facilitator Fund award to PSU startup company Hawthorne Materials Corp. Hawthorne Materials Corp. is developing x-ray opaque materials for the medical device and imaging market. Their initial focus is on foreign retained objects - items accidentally left in the body after surgery. The funds will be used to complete tests to move their devices closer to FDA approval.
- Facilitator Fund award to PSU startup company Pacific NanoSciences. Pacific NanoSciences is developing a handheld point-of-care product for the rapid, ultrasensitive detection of diseases. Their initial focus is on the identification of cardiovascular risk factors. The funds will be used to create an in-depth financial model based on market research and a comprehensive competitive analysis to assist in the demonstration of a business case that is appealing to Series A investors.
- Facilitator Fund award to PSU startup company Virtual Device Technologies. Virtual Device Technologies is developing software based on research at PSU, and is on the process of building a product with a multinational alpha customer. The funds will be used to hire a part-time software devleoper.
- Promotion Fund grant to create marketing materials for the new documentary Guilty Except for Insanity. This documentary has had regional showings to great acclaim, and IIP has worked with an agent to pitch the documentary to broadcast and other networks. The funds allowed for the creation of a professionally produced “trailer” for the movie, which now helps demonstrate the movie’s important analysis of the medical treatment received by convicted criminals who plead “insanity”.
- Promotion Fund grant to support travel to limited companies to demonstrate a patented technology in computer security, which has garnered interest from e-mail providers and other companies.
- Development Fund grant to help construct a bench-top prototype to showcase a new kind of microscope to industry partners and collaborators. The new device and methodology is geared towards imaging material and fault detection. The project has received feedback from microscope manufacturers and has an allowed patent with more forthcoming soon.
- Development Fund grant to perform initial proof of concept and animal studies for compounds with the potential to be drug candidates for treating heart arrhythmias. The data will support additional grant filings and the formation of a start-up company focused on the further development of the compounds.
- Development Fund grant to support the development of a field ready prototype of a low cost, fast, and accurate sensor for measuring nitrogen dioxide and other gases. The prototype may in turn support the formation of a start-up company focused on the further development of these sensors.